Dr. Agrawal'sEye Hospital and Eye Resaearch Center, Chennai, India.
J Refract Surg. 2013 May;29(5):342-7. doi: 10.3928/1081597X-20130415-05.
To determine the outcome after glued aniridia intraocular lens (IOL) and glued IOL with iridoplasty in eyes with combined lens capsular and iris deficiency.
Twenty-seven eyes of 25 patients (6 had congenital aniridia with subluxated cataract and 19 had acquired lens/iris defects) were included. Glued IOL with aniridia IOL (Intra Ocular Care, Gujarat, India) was performed in eyes with total aniridia and iridoplasty with glued IOL with a three-piece foldable IOL (Sofport; Bausch & Lomb, Rochester, NY) was performed in eyes with partial aniridia. The postoperative outcomes were analyzed at follow-up examination (range: 6 to 48 months).
Eleven eyes underwent glued aniridia IOL and 16 eyes underwent glued IOL with iridoplasty. There was significant improvement in (spectacle) corrected distance visual acuity (CDVA) (P = .002). Postoperatively, pigment dispersion on the IOL (n = 1) and raised intraocular pressure was seen in the glued aniridia IOL group and chronic uveitis (n = 1), cystoid macular edema (n = 1), and hyphema (n = 1) in the glued IOL with iridoplasty group. The CDVA remained unchanged in 14 eyes (51.8%) and improved in 13 eyes (48.1%). There was a difference in postoperative CDVA (P = .001) between eyes with glued aniridia IOL and glued IOL with iridoplasty. There was no IOL decentration, retinal detachment, corneal decompensation, or endophthalmitis. There was reduction in glare and photophobia.
Both glued aniridia IOL and glued IOL/iridoplasty showed good functional and anatomical results with fewer complications in eyes with lens capsule and iris deficiency. However, long-term follow-up is required.[J Refract Surg. 2013;29(5):342-347.].
评估在晶状体囊膜和虹膜缺损的患眼中,应用粘合法虹膜植入型人工晶状体(IOL)和粘合法 IOL 联合虹膜成形术的治疗效果。
纳入 25 名患者(6 名患有先天性无虹膜伴晶状体半脱位和 19 名患有获得性晶状体/虹膜缺损)的 27 只眼。对于完全性无虹膜的患眼,行粘合法虹膜植入型人工晶状体(Intra Ocular Care,印度古吉拉特邦)植入术;对于部分性无虹膜的患眼,行粘合法 IOL 联合三件式折叠式 IOL(Sofport;Bausch & Lomb,纽约罗彻斯特)虹膜成形术。术后随访(6 至 48 个月),分析其术后结果。
11 只眼行粘合法虹膜植入型人工晶状体植入术,16 只眼行粘合法 IOL 联合虹膜成形术。(眼镜)矫正远距视力(CDVA)显著提高(P=.002)。粘合法虹膜植入型人工晶状体组有 1 只眼出现 IOL 色素播散,1 只眼出现眼压升高;粘合法 IOL 联合虹膜成形术组有 1 只眼出现慢性葡萄膜炎、1 只眼出现黄斑囊样水肿、1 只眼出现前房积血。14 只眼(51.8%)的 CDVA 保持不变,13 只眼(48.1%)的 CDVA 提高。粘合法虹膜植入型人工晶状体组和粘合法 IOL 联合虹膜成形术组的术后 CDVA 有差异(P=.001)。两组均未出现 IOL 偏心、视网膜脱离、角膜失代偿或眼内炎。术后畏光和眩光减轻。
在晶状体囊膜和虹膜缺损的患眼中,应用粘合法虹膜植入型人工晶状体和粘合法 IOL 联合虹膜成形术,其功能和解剖效果良好,并发症较少。但需要长期随访。